115 related articles for article (PubMed ID: 16802081)
1. 2D autocorrelation modelling of the inhibitory activity of cytokinin-derived cyclin-dependent kinase inhibitors.
González MP; Caballero J; Helguera AM; Garriga M; González G; Fernández M
Bull Math Biol; 2006 May; 68(4):735-51. PubMed ID: 16802081
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses.
Caballero J; Fernández M; González-Nilo FD
Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903
[TBL] [Abstract][Full Text] [Related]
3. Bayesian-regularized genetic neural networks applied to the modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.
Fernández M; Caballero J
J Mol Graph Model; 2006 Dec; 25(4):410-22. PubMed ID: 16574448
[TBL] [Abstract][Full Text] [Related]
4. 2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks.
Caballero J; Garriga M; Fernández M
Bioorg Med Chem; 2006 May; 14(10):3330-40. PubMed ID: 16442799
[TBL] [Abstract][Full Text] [Related]
5. Modeling of activity of cyclic urea HIV-1 protease inhibitors using regularized-artificial neural networks.
Fernández M; Caballero J
Bioorg Med Chem; 2006 Jan; 14(1):280-94. PubMed ID: 16202604
[TBL] [Abstract][Full Text] [Related]
6. Modeling of cyclin-dependent kinase inhibition by 1H-pyrazolo[3,4-d]pyrimidine derivatives using artificial neural network ensembles.
Fernández M; Tundidor-Camba A; Caballero J
J Chem Inf Model; 2005; 45(6):1884-95. PubMed ID: 16309296
[TBL] [Abstract][Full Text] [Related]
7. Modeling of farnesyltransferase inhibition by some thiol and non-thiol peptidomimetic inhibitors using genetic neural networks and RDF approaches.
González MP; Caballero J; Tundidor-Camba A; Helguera AM; Fernández M
Bioorg Med Chem; 2006 Jan; 14(1):200-13. PubMed ID: 16185882
[TBL] [Abstract][Full Text] [Related]
8. Predictive QSAR modeling of HIV reverse transcriptase inhibitor TIBO derivatives.
Mandal AS; Roy K
Eur J Med Chem; 2009 Apr; 44(4):1509-24. PubMed ID: 18760864
[TBL] [Abstract][Full Text] [Related]
9. Proteochemometric modeling of the inhibition complexes of matrix metalloproteinases with N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives using topological autocorrelation interaction matrix and model ensemble averaging.
Fernández M; Fernández L; Caballero J; Abreu JI; Reyes G
Chem Biol Drug Des; 2008 Jul; 72(1):65-78. PubMed ID: 18554254
[TBL] [Abstract][Full Text] [Related]
10. QSAR modeling of the inhibition of glycogen synthase kinase-3.
Katritzky AR; Pacureanu LM; Dobchev DA; Fara DC; Duchowicz PR; Karelson M
Bioorg Med Chem; 2006 Jul; 14(14):4987-5002. PubMed ID: 16650999
[TBL] [Abstract][Full Text] [Related]
11. Feature selection and linear/nonlinear regression methods for the accurate prediction of glycogen synthase kinase-3beta inhibitory activities.
Goodarzi M; Freitas MP; Jensen R
J Chem Inf Model; 2009 Apr; 49(4):824-32. PubMed ID: 19338295
[TBL] [Abstract][Full Text] [Related]
12. CDK1-inhibitory activity of paullones depends on electronic properties of 9-substituents.
Pies T; Schaper KJ; Leost M; Zaharevitz DW; Gussio R; Meijer L; Kunicke C
Arch Pharm (Weinheim); 2004 Sep; 337(9):486-92. PubMed ID: 15362121
[TBL] [Abstract][Full Text] [Related]
13. Linear and nonlinear QSAR study of N-hydroxy-2-[(phenylsulfonyl)amino]acetamide derivatives as matrix metalloproteinase inhibitors.
Fernández M; Caballero J; Tundidor-Camba A
Bioorg Med Chem; 2006 Jun; 14(12):4137-50. PubMed ID: 16504515
[TBL] [Abstract][Full Text] [Related]
14. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
Fernández M; Caballero J
Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
[TBL] [Abstract][Full Text] [Related]
15. Application of partial least squares and radial basis function neural networks in multivariate imaging analysis-quantitative structure activity relationship: study of cyclin dependent kinase 4 inhibitors.
Saghaie L; Shahlaei M; Madadkar-Sobhani A; Fassihi A
J Mol Graph Model; 2010 Dec; 29(4):518-28. PubMed ID: 21071247
[TBL] [Abstract][Full Text] [Related]
16. Discovery of cyclin-dependent kinase inhibitor, CR229, using structurebased drug screening.
Kim MK; Min J; Choi BY; Lim H; Cho YH; Lee CH
J Microbiol Biotechnol; 2007 Oct; 17(10):1712-6. PubMed ID: 18156791
[TBL] [Abstract][Full Text] [Related]
17. Prediction of mammalian toxicity of organophosphorus pesticides from QSTR modeling.
Devillers J
SAR QSAR Environ Res; 2004; 15(5-6):501-10. PubMed ID: 15669705
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the concentration of chlorophyll-a for Liuhai urban lakes in Beijing City.
Zeng Y; Yang ZF; Liu JL
J Environ Sci (China); 2006; 18(4):827-31. PubMed ID: 17078569
[TBL] [Abstract][Full Text] [Related]
19. QSAR study of malonyl-CoA decarboxylase inhibitors using GA-MLR and a new strategy of consensus modeling.
Li J; Lei B; Liu H; Li S; Yao X; Liu M; Gramatica P
J Comput Chem; 2008 Dec; 29(16):2636-47. PubMed ID: 18484640
[TBL] [Abstract][Full Text] [Related]
20. QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.
Jalali-Heravi M; Asadollahi-Baboli M; Shahbazikhah P
Eur J Med Chem; 2008 Mar; 43(3):548-56. PubMed ID: 17602800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
